VANCOUVER, BC, Nov. 26, 2021 /CNW/ - Numinus Wellness Inc.
("Numinus" or the "Company") (TSXV: NUMI), a mental health care
company advancing innovative treatments and safe, evidence-based
psychedelic-assisted therapies, is pleased to announce that it has
received conditional approval from the Toronto Stock Exchange
("TSX") to graduate its listing from the TSX Venture Exchange (the
"TSXV") to the TSX.
"This is an important milestone for Numinus, as we take key
steps to heighten our corporate profile and reach a broader range
of investors," said Payton Nyquvest,
Founder and CEO of Numinus. "Today's announcement is reflective of
many exciting developments occurring at Numinus. We're actively
growing our clinic network across North
America, expanding our lab capabilities, and strategically
investing in clinical research to drive long-term value creation
for our investors."
Final approval of the listing is subject to the Company
fulfilling certain standard and customary conditions required by
the TSX. Numinus' management team is working diligently to satisfy
such listing conditions. A timeline for the graduation will be
announced once the Company receives final approval.
Upon listing on the TSX, the Company's common shares will
continue to trade under the symbol "NUMI", and its outstanding
listed warrants will continue to trade under the symbols "NUMI.WT",
"NUMI.WT.B" and "NUMI.WT.C".
Numinus Wellness helps people to heal
and be well through the development and delivery of innovative
mental health care and access to safe, evidence-based
psychedelic-assisted therapies. The Numinus model – including
psychedelic production, research and clinic care – is at the
forefront of a transformation aimed at healing rather than managing
symptoms for depression, anxiety, trauma, pain and substance use.
At Numinus, we are leading the integration of psychedelic-assisted
therapies into mainstream clinical practice and building the
foundation for a healthier society.
Learn more at www.numinus.com and follow us
on LinkedIn, Facebook, Twitter,
Statements and other
information contained in this press release about anticipated
future events constitute forward-looking statements.
Forward-looking statements are often, but not always, identified by
the use of words such as "seek", "anticipate", "believe", "plan",
"estimate", "expect" and "intend" and statements that an event
"may", "will", "should", "could" or "might" occur or other similar
expressions. Forward-looking statements are subject to risks and
uncertainties and other factors that could cause actual results to
differ materially from those contained in the forward-looking
statements. Forward-looking statements are based on estimates and
opinions of management at the date the statements are made. The
Company does not undertake any obligation to update forward-looking
statements even if circumstances or management's estimates or
opinions should change except as required by applicable laws.
Investors should not place undue reliance on forward-looking
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE Numinus Wellness Inc.